210 related articles for article (PubMed ID: 35836178)
41. Tolerogenic dendritic cells show gene expression profiles that are different from those of immunogenic dendritic cells in DBA/1 mice.
Lee EG; Jung NC; Lee JH; Song JY; Ryu SY; Seo HG; Han SG; Ahn KJ; Hong KS; Choi J; Lim DS
Autoimmunity; 2016; 49(2):90-101. PubMed ID: 26699759
[TBL] [Abstract][Full Text] [Related]
42. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
43. Dendritic cells as targets for therapy in rheumatoid arthritis.
Khan S; Greenberg JD; Bhardwaj N
Nat Rev Rheumatol; 2009 Oct; 5(10):566-71. PubMed ID: 19798032
[TBL] [Abstract][Full Text] [Related]
44. Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cells.
Carranza F; Falcón CR; Nuñez N; Knubel C; Correa SG; Bianco I; Maccioni M; Fretes R; Triquell MF; Motrán CC; Cervi L
PLoS One; 2012; 7(7):e40356. PubMed ID: 22848374
[TBL] [Abstract][Full Text] [Related]
45. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.
Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R
Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748
[TBL] [Abstract][Full Text] [Related]
46. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.
Morita Y; Yang J; Gupta R; Shimizu K; Shelden EA; Endres J; Mulé JJ; McDonagh KT; Fox DA
J Clin Invest; 2001 May; 107(10):1275-84. PubMed ID: 11375417
[TBL] [Abstract][Full Text] [Related]
47. The type I IFN system in rheumatoid arthritis.
Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G
Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872
[TBL] [Abstract][Full Text] [Related]
48. Treatment mechanism of tolerogenic dendritic cells on rheumatoid arthritis.
Wang XY; Zhang JY
J Biol Regul Homeost Agents; 2018; 32(5):1239-1244. PubMed ID: 30334419
[TBL] [Abstract][Full Text] [Related]
49. Comparison of Tolerogenic Dendritic Cells Induced by Liver X Receptor Agonist from Bone Marrow-derived Cells and Natural Tolerogenic Dendritic Cells.
Xu H; Ma X; Song D; Xue D; He X; Zhang X
Clin Lab; 2016; 62(3):249-61. PubMed ID: 27156312
[TBL] [Abstract][Full Text] [Related]
50. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
51. CD1d blockade suppresses the capacity of immature dendritic cells to prime allogeneic T cell response.
Ma ZH; Lu H; Lu Q; Yao ZF; Han Y
J Surg Res; 2013 Aug; 183(2):894-9. PubMed ID: 23478084
[TBL] [Abstract][Full Text] [Related]
52. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.
Jaen O; Rullé S; Bessis N; Zago A; Boissier MC; Falgarone G
Immunology; 2009 Jan; 126(1):35-44. PubMed ID: 18754812
[TBL] [Abstract][Full Text] [Related]
53. Activation of formyl peptide receptor 1 elicits therapeutic effects against collagen-induced arthritis.
Park B; Lee M; Kim SD; Jeong YS; Kim JC; Yang S; Kim HY; Bae YS
J Cell Mol Med; 2021 Sep; 25(18):8936-8946. PubMed ID: 34378309
[TBL] [Abstract][Full Text] [Related]
54. Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs.
Wu J; Liu M; Mang G; Yu S; Chen Q; Li T; Wang Y; Meng Y; Tang X; Zheng Y; Sun Y; Zhang M; Yu B
Pharmacol Res; 2019 Aug; 146():104269. PubMed ID: 31078745
[TBL] [Abstract][Full Text] [Related]
55. Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.
García-González PA; Schinnerling K; Sepúlveda-Gutiérrez A; Maggi J; Hoyos L; Morales RA; Mehdi AM; Nel HJ; Soto L; Pesce B; Molina MC; Cuchacovich M; Larrondo ML; Neira Ó; Catalán DF; Hilkens CM; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2016; 7():458. PubMed ID: 27826300
[TBL] [Abstract][Full Text] [Related]
56. Piperlongumine Suppresses Dendritic Cell Maturation by Reducing Production of Reactive Oxygen Species and Has Therapeutic Potential for Rheumatoid Arthritis.
Xiao Y; Shi M; Qiu Q; Huang M; Zeng S; Zou Y; Zhan Z; Liang L; Yang X; Xu H
J Immunol; 2016 Jun; 196(12):4925-34. PubMed ID: 27183580
[TBL] [Abstract][Full Text] [Related]
57. Dose-Dependent Efficacy of Umbelliferone and Gelatin-Coated ZnO/ZnS Core-Shell Nanoparticles: A Novel Arthritis Agent for Severe Knee Arthritis.
Zheng Y; Lakshmanan S
Oxid Med Cell Longev; 2022; 2022():7795602. PubMed ID: 35432722
[TBL] [Abstract][Full Text] [Related]
58. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
[TBL] [Abstract][Full Text] [Related]
59. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation.
Papadaki G; Kambas K; Choulaki C; Vlachou K; Drakos E; Bertsias G; Ritis K; Boumpas DT; Thompson PR; Verginis P; Sidiropoulos P
Eur J Immunol; 2016 Nov; 46(11):2542-2554. PubMed ID: 27585946
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
